欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是 分享到:

中国临床药理学与治疗学 ›› 2021, Vol. 26 ›› Issue (4): 368-375.doi: 10.12092/j.issn.1009-2501.2021.04.002

• 基础研究 • 上一篇    下一篇

三叶青总黄酮逆转吉非替尼耐药肺腺癌细胞的耐药性

何佳奇1,李娟娟1,吕晓皑1,张欢欢2,余陈欢2,3   

  1. 1浙江中医药大学附属第一医院,杭州 310006,浙江;2杭州医学院实验动物中心,杭州 310013,浙江;3中国科学院肿瘤与基础医学研究所,杭州 310018,浙江

  • 收稿日期:2020-12-21 修回日期:2021-01-30 出版日期:2021-04-26 发布日期:2021-05-11
  • 通讯作者: 余陈欢,男,博士,副研究员,研究方向:肿瘤表观遗传发病机制及其治疗。 Tel: 0571-88120179 E-mail: yuchenhuan2002@163.com
  • 作者简介:何佳奇,女,博士,主管中药师,研究方向:中药抗肿瘤药效物质及其作用机制。 Tel: 0571-87073482 E-mail: hejiaqi7788@sina.com
  • 基金资助:
    浙江省中医药科技计划项目(2020ZB077);浙江省科技计划项目(2015F50056)

Reversal effects and mechanisms of Flavonoids from Tetrastigma hemsleyanum on drug resistance in gefitinib-resistant lung cancer cells

HE Jiaqi 1, LI Juanjuan 1, LV Xiaoai 1, ZHANG Huanhuan 2, YU Chenhuan 2,3   

  1. 1 The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou 310006, Zhejiang, China; 2 Laboratory Animal Center, Hangzhou Medical Collage, Hangzhou 310013, Zhejiang, China; 3 Institute of Cancer and Basic Medicine, Chinese Academy of Sciences, Hangzhou 310018, Zhejiang, China

  • Received:2020-12-21 Revised:2021-01-30 Online:2021-04-26 Published:2021-05-11

摘要: 目的:探讨三叶青总黄酮(FTH)逆转吉非替尼(GEF)耐药肺腺癌细胞的耐药性及其初步机制。方法:采用MTT法,检测FTH对GEF耐药A549/GR细胞增殖的影响;采用流式细胞技术检测FTH对A549/GR细胞凋亡及周期的影响;建立A549/GR细胞荷瘤小鼠模型,观察两药联用后的体内抑瘤效果;采用Western blot法检测瘤组织PI3K/Akt信号通路关键蛋白(PTEN、PI3K、p-PI3K、AKT、p-AKT)的表达情况。结果:与单用GEF相比,FTH联合GEF给药可显著抑制A549/GR细胞增殖(P<0.05),诱导A549/GR细胞凋亡(P<0.05),使细胞停滞在G0/G1期。体内实验结果表明,两者联合可显著抑制裸鼠A549/GR移植瘤的生长(P<0.05),并显著降低瘤组织p-PI3K和p-AKT表达(P<0.05),升高PTEN蛋白表达(P<0.05)。 结论:FTH可逆转A549/GR细胞对GEF的耐药性,其作用机制可能与调控PTEN/PI3K/AKT通路有关。

关键词: 三叶青, 黄酮, EGFR-TKIs, 耐药, PTEN/PI3K/AKT

Abstract: AIM: To investigate the sensitization of flavonoids from Tetrastigma hemsleyanum (FTH) on gefitinib (GEF)-resistant lung adenocarcinoma cells.  METHODS: The viabilities of A549 and A549/GR cells treated with FTH and GEF were detected by MTT method. The apoptotic rates and cell cycles of A549/GR cells treated with FTH and GEF were detected by Flow cytometry. The anti-tumor effects of flavonoids from FTH and GEF were assayed in A549/GR tumor-bearing mice. The expressions of proteins (PTEN, PI3K, p-PI3K, AKT, p-AKT) were detected by Western blot analysis. RESULTS: Compared with GEF group, FTH significantly enhanced the inhibition of GEF on the proliferation of A549/GR cells (P<0.05). Combination with FTH and GEF significantly increased the apoptosis of A549/GR cells which were arrested at the G0/G1 stage (P<0.05). The in vivo results showed that combination with FTH and GEF significantly inhibited the tumor growth of A549/GR in mice (P<0.05). Furthermore, this combination significantly downregulated the expressions of p-PI3K and p-AKT (P<0.05), but upregulated the expressions of PTEN (P<0.05). CONCLUSION: FTH increases the sensitivity to gefitinib by modulating PTEN/PI3K/AKT pathway in acquired GEF resistance of non-small cell lung cancer.

Key words: Tetrastigma hemsleyanum Radix, flavonoids, EGFR-TKIs, resistance, PTEN/PI3K/AKT

中图分类号: